Baba H A, Iwai T, Bauer M, Irlbeck M, Schmid K W, Zimmer H G
Gerhard-Domagk-Institute of Pathology, University of Münster, Germany.
J Mol Cell Cardiol. 1999 Feb;31(2):445-55. doi: 10.1006/jmcc.1998.0879.
The effects of the angiotensin II receptor type 1 (AT1) antagonist losartan on pressure overload-induced left ventricular (LV) hypertrophy were studied in female Sprague-Dawley rats. Starting on the day of surgery, losartan (L, 12 mg/kg/day) was administered as continuous intraperitoneal infusion for 2 weeks by using alzet mini-osmotic-pumps (model 2002). This dose of losartan shifted the in vivo dose-response curve of the angiotensin II-induced elevation of left ventricular systolic pressure (LVSP) to the right. Pressure overload was achieved by placing a band around the aortic arch. This caused an aortic stenosis (AS) with an outer diameter of 1.0 mm. The hemodynamic effects were measured in the intact, anesthetized rats (n = 15). The hearts were excised, and the weights of the left (LV) and right ventricle (RV) were determined. Some of these hearts (n = 7) were perfused with collagenase to obtain isolated cardiac myocytes for the measurement of cell volume. Other hearts (n = 8) were examined for morphological changes. In the animals with AS, LVSP was markedly elevated. Furthermore, LV weight and LV myocyte cell volume were increased in this group, while RV weight and RV myocyte cell volume remained stable in all the groups. L had no significant effect on the AS-induced increase in LVSP and cell size parameters, nor on the weight gain of the LV. Histological analysis revealed that the AS-induced enlargement of the mean myocyte diameter was not affected by L. The interstitial collagen fraction was increased in the AS rats and became normalized by L. These data suggest that the renin-angiotensin system might not be involved in the development of pressure-induced cardiac hypertrophy within the time-frame of these experiments, but that it does play a major role in the genesis of the interstitial fibrosis which is a typical feature of this pathophysiological condition.
在雌性斯普拉格-道利大鼠中研究了血管紧张素II 1型(AT1)拮抗剂氯沙坦对压力超负荷诱导的左心室(LV)肥厚的影响。从手术当天开始,使用alzet微型渗透泵(型号2002)以连续腹腔内输注的方式给予氯沙坦(L,12毫克/千克/天),持续2周。该剂量的氯沙坦使血管紧张素II诱导的左心室收缩压(LVSP)升高的体内剂量反应曲线右移。通过在主动脉弓周围放置一条带子实现压力超负荷。这导致了外径为1.0毫米的主动脉狭窄(AS)。在完整的麻醉大鼠(n = 15)中测量血流动力学效应。切除心脏,测定左心室(LV)和右心室(RV)的重量。其中一些心脏(n = 7)用胶原酶灌注以获得分离的心肌细胞用于测量细胞体积。检查其他心脏(n = 8)的形态学变化。在患有AS的动物中,LVSP明显升高。此外,该组中左心室重量和左心室心肌细胞体积增加,而所有组中的右心室重量和右心室心肌细胞体积保持稳定。L对AS诱导的LVSP和细胞大小参数增加以及左心室重量增加没有显著影响。组织学分析显示,AS诱导的平均心肌细胞直径增大不受L影响。AS大鼠的间质胶原分数增加,L使其恢复正常。这些数据表明,在这些实验的时间范围内,肾素-血管紧张素系统可能不参与压力诱导的心脏肥厚的发展,但它在间质纤维化的发生中起主要作用,间质纤维化是这种病理生理状况的典型特征。